A 53-year-old woman had difficulty in walking, raised titres to human T-lymphotropic virus type 1 (HTLV-1) in serum and cerebrospinal fluid, and yellowish white retinal lesions and vasculitis in the right eye. Her 20-year-old son also had difficulty in walking, raised titres to HTLV-1 in serum and cerebrospinal fluid, and retinal vasculitis and multiple whitish vitreoretinal spots in both eyes.
Human T-lymphotropic virus type 1 (HTLV-1) causes adult T-cell leukaemia/lymphoma (ATLL) and HTLV-1 associated myelopathy (HAM)." 2 phy, and magnetic resonance imaging showed normal findings. The patient was treated with prednisolone, 100 mg/day; thereafter the drug was tapered to 15 mg/day.
In July 1990 no retinal lesions were found. In August her right visual acuity had decreased to 20/30. Cells were noted in the right anterior chamber. Whitish yellow lesions were found in the right temporal fundus (Fig 1) . In addition multiple whitish dots were noted round the retinal veins. Fluorescein angiography showed that the retinal venous lesions did not leak (Fig 2) . Routine laboratory test results were negative or within normal range, including blood pressure; blood glucose level; serum titres to adenovirus, herpes simplex virus, cytomegalovirus, varicella zoster virus, immunodeficiency virus, and toxoplasma; angiotensin-converting enzyme level; IgG; IgM; C-reactive protein; Treponema pallidum haemagglutinin; antibody to DNA; antinuclear antibody; rheumatoid arthritis factor; tuberculin skin test; and chest x ray findings. No oral aphthae or genital ulcers were noted.
In September 1990 systemic prednisolone, 100 mg/day, diminished the cells in the right anterior chamber but had no effect on the yellowish white lesions or the retinal vasculitis. The prednisolone was tapered again to 15 mg/ day. In October the retinal lesions in the right eye gradually diminished. Her right visual acuity improved to 20/20.
Retinal vasculitis in a mother and her son with human T-lymphotropic virus type I associated myelopathy CASE 2 The previously healthy 20-year-old son of case 1 complained of problems in walking in October 1989. The disorder was slowly progressive and was followed by spastic paraparesis. Results of routine tests were negative or within the normal range. A small number of atypical lymphocytes were found in his peripheral blood, and raised titres to HTLV-1 were noted in serum (1:8192) and cerebrospinal fluid (1:128). Myelography, computed tomography, and magnetic resonance imaging gave normal findings. No retinal lesions were found. The patient was treated with prednisolone, 50 mg/day. The gait disturbance improved, and the corticosteroid was tapered.
In June 1990 the patient complained of floating spots in both eyes. The corrected visual acuity in both eyes was 20/20. The corneas and anterior chambers were transparent. Small opacities were observed in the vitreous in both eyes. Multiple The present study suggests that antibody titres to HTLV-1 in serum and cerebrospinal fluid of patients with retinal vasculitis should be examined.
